Results 341 to 350 of about 9,168,778 (393)
RETRACTION: The Impact of Glucocorticoids Therapy on Cutaneous Wounds in Kawasaki Disease: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Int Wound Jeuropepmc +1 more source
An infant with IVIG-resistant Kawasaki disease requiring repeated glucocorticoids therapy: A case report and literature review. [PDF]
Medicine (Baltimore)Ren Y.
europepmc +1 more source
Progressive coronary aneurysms in Kawasaki disease: A case report and long-term follow-up. [PDF]
Radiol Case RepSaliba T +3 more
europepmc +1 more source
Incomplete Kawasaki Disease in an Adult Complicated by Stroke. [PDF]
CureusJafri AD +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Arthritis & Rheumatology, 2022
To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists.
M. Gorelik +40 more
semanticscholar +2 more sources
To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists.
M. Gorelik +40 more
semanticscholar +2 more sources
Current Treatment Options in Cardiovascular Medicine, 2004
Kawasaki disease is an acute, self-limited vasculitis of childhood characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in approximately 15 to 25% of untreated children with the disease and may ...
David Fulton, Jane W. Newburger
openaire +6 more sources
Kawasaki disease is an acute, self-limited vasculitis of childhood characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy. Coronary artery aneurysms or ectasia develop in approximately 15 to 25% of untreated children with the disease and may ...
David Fulton, Jane W. Newburger
openaire +6 more sources
Vascular Medicine, 1999
Kawasaki disease is a leading cause of acquired heart disease in children in the USA. An acute vasculitis of unknown etiology, it occurs predominantly in infancy and early childhood, and more rarely in teenagers. Coronary artery aneurysms or ectasia develop in approximately 15-25% of children with the disease. Treatment with intravenous gamma globulin,
J W, Newburger, J C, Burns
openaire +2 more sources
Kawasaki disease is a leading cause of acquired heart disease in children in the USA. An acute vasculitis of unknown etiology, it occurs predominantly in infancy and early childhood, and more rarely in teenagers. Coronary artery aneurysms or ectasia develop in approximately 15-25% of children with the disease. Treatment with intravenous gamma globulin,
J W, Newburger, J C, Burns
openaire +2 more sources
The Journal of the American Dental Association, 1982
Kawasaki’s disease can cause cardiac changes. Such changes have implications for dental treatment.
Devereaux S. Peterson, Mark H. Taylor
openaire +2 more sources
Kawasaki’s disease can cause cardiac changes. Such changes have implications for dental treatment.
Devereaux S. Peterson, Mark H. Taylor
openaire +2 more sources
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin–Resistant Kawasaki Disease
Arthritis & Rheumatology, 2020Anakinra has been shown to be successful in preventing and treating cardiovascular lesions both in experimental murine models of Kawasaki disease (KD) and in several studies on intravenous immunoglobulin (IVIG)– and steroid‐resistant patients with KD ...
I. Koné-Paut +13 more
semanticscholar +1 more source